Idifarma Invests in Automatic Capsule Filling Capabilities
PTSM: Pharmaceutical Technology Sourcing and Management
Idifarma has acquired a Bosch GKF-702 capsule filling machine that can manufacture 3000 to 42,000 capsules per hour.
Spanish CDMO, Idifarma, announced that it has invested in an automated capsule filling equipment. The Bosch GKF-702 capsule filling machine can manufacture 3000 to 42,000 capsules per hour. The GKF-702 features a “lab kit” that enables the use of the machine during pharmaceutical development, so that APIs are used more efficiently and wastage is reduced.
The new equipment will be installed at the CDMO’s EU-GMP approved plant in Pamplona, Spain, in early 2017. This investment expands Idifarma’s GMP manufacturing offering. Other equipment already installed at Idifarma’s GMP plant include a Hüttlin Oyster high-shear mixer and dryer for wet granulation processes, bin blenders with capacity up to 70 kg, and a Clinipack IMA blistering machine, with the ability to work with Alu/Alu or any thermo-formable material.
Source: Idifarma
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
